Author Question: The ________ is not included in the prefatory parts of a formal report. A) introduction B) ... (Read 128 times)

shenderson6

  • Hero Member
  • *****
  • Posts: 573
The ________ is not included in the prefatory parts of a formal report.
 
  A) introduction
  B) letter of authorization
  C) letter of transmittal
  D) table of contents
  E) executive summary

Question 2

Within the context of preparing formal reports and proposals, the term limitations
 
  A) sets the boundaries of your research, that is, what you will and will not investigate.
  B) presents excuses for inadequate research or a poorly written report.
  C) specifies the risks, rewards, costs, and benefits of a specific course of action.
  D) refers to factors beyond your control that affect the quality of the report.
  E) specifies what will happen if the solution is not accepted.
  c



shoemake

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Answer: A
Explanation: A) The introduction is included in the report as a text part, not a prefatory part.

Answer to Question 2

Answer: D
Explanation: D) If factors beyond your control have affected the outcome of your report, discuss those limitations in the introduction to the report.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Throughout history, plants containing cardiac steroids have been used as heart drugs and as poisons (e.g., in arrows used in combat), emetics, and diuretics.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library